Part 2: Human Medicines Chapter 2: International Agreements: Disclosure of Information Section 8: Disclosure of information in accordance with international agreements
Section 8 confers a power on the Secretary of State and the Department of Health in Northern Ireland to disclose information they hold relating to human medicines.
	Section (2) provides that information may be disclosed to a relevant person outside the UK where it is required in order to give effect to international agreements and arrangements concerning the regulation of human medicines and the relevant authority considers that the disclosure is in the public interest.
	Subsection (3) provides that the relevant authority may not disclose commercially sensitive information under this section unless the relevant authority considers the disclosure to be necessary and proportionate.
	Subsection (4) sets out that, except as provided by subsections (5) and (6), any disclosure of information in accordance with this section does not breach the restrictions on disclosure at (a) and (b).
	Subsection (5) provides a restriction requiring that identifiable patient information is only shared with the patient's consent.
	Subsection (6) provides that nothing in this section allows disclosures of information that breach data protection legislation or are prohibited by Parts 1 to 7 or Chapter 1 of Part 9 of the Investigatory Powers Act 2016  .
	Subsection (7) makes it clear that this section does not limit the circumstances in which information may be disclosed under any other enactment or rule of law (for example under common law powers).
	Subsection (8) provides definitions for terms used in section 8.